NCT00278538View on ClinicalTrials.gov

Cyclophosphamide and Rabbit Antithymocyte Globulin (rATG)/Rituximab in Patients With Systemic Lupus Erythematosus

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 23, 2005

Primary Completion Date

December 31, 2018

Study Completion Date

May 31, 2019

Conditions
Systemic Lupus Erythematosus
Interventions
BIOLOGICAL

Hematopoietic stem cell transplantation

Autologous hematopoietic stem cell transplantation

Trial Locations (2)

60611

Northwestern University, Feinberg School of Medicine, Chicago

Northwestern University, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER

NCT00278538 - Cyclophosphamide and Rabbit Antithymocyte Globulin (rATG)/Rituximab in Patients With Systemic Lupus Erythematosus | Biotech Hunter | Biotech Hunter